29-Sept-2026 10:59:30
PIRAMAL PHARMA LIMITED : CHALLENGES RS 4.06 CR GST DEMAND AND PENALTY
• Company received an Order-in-Original on September 28, 2026, from Additional Commissioner, CGST & Central Excise, Mumbai East Commissionerate, concerning GST audit for FY 2020-21 to FY 2022-23. • The order relates to the eligibility of input tax credits, including those pertaining to post-demerger transition period, ISD registration, and overseas procurement support. • Authority confirmed a demand of Input Tax Credit (ITC) aggregating to ₹4.06 Cr along with applicable interest and imposed an equivalent penalty of ₹4.06 Cr. • The company believes it has a meritorious case and intends to challenge the order by filing an appeal. • The company does not expect any material impact on its financials, operations, or other activities.
Piramal Pharma Limited
Open attachment